2:00pm GMT
Webcast can be found here:
https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/AiNMtuh48fswKWQWx9zoQu
Webcast details? Corporate governance? Financial reports? Find everything you need as an investor or analyst here!
LKFT Euronext
Lakefront Biotherapeutics NV
LKFT Nasdaq – USD
Lakefront Biotherapeutics NV
Lakefront Biotherapeutics is a biotechnology company building a differentiated clinical-stage pipeline in immunology and inflammation, anchored by lead asset gamgertamig, a potential first-in-class BCMAxCD3 T-cell engager for autoimmune diseases.
With deep deal-making expertise, operational flexibility, and a strong capital position, Lakefront identifies, acquires, and advances high-quality assets with clear potential to deliver meaningful patient impact and long-term shareholder value.
| Date | Details |
|---|---|
| February 24, 2027 | Full-year results 2026 |
| March 25, 2027 | Annual report 2026 |
| April 27, 2027 | Annual General Shareholders’ Meeting |
| May 3, 2027 | First quarter results 2027 |
| August 4, 2027 | Half-year results 2027 |
| November 3, 2027 | Third quarter results 2027 |
2:00pm GMT
Webcast can be found here:
https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/AiNMtuh48fswKWQWx9zoQu
Lakefront will hold a conference call and webcast for investors following the day of presentation, on Monday, December 14 at 8:00 AM ET. To participate in the conference call, please register in advance using this link. Dial-in numbers will be provided upon registration. The conference call can be accessed 10 minutes prior to the start of the call by using the conference access information provided in the email received after registration, or by selecting the “call me” feature. The live webcast is available on https://lakefrontbio.com/events-presentations/ or via the following link.
Press Releases
Want to keep up with our journey as we are advancing medicines that matter?